Clearmind Medicine (Clearmind Medicine) Marketable Securities : $0.09 Mil (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Clearmind Medicine's Marketable Securities for the quarter that ended in Jan. 2024 was $0.09 Mil.

Clearmind Medicine's annual Marketable Securities increased from Oct. 2021 ($0.00 Mil) to Oct. 2022 ($0.14 Mil) but then declined from Oct. 2022 ($0.14 Mil) to Oct. 2023 ($0.06 Mil).

Clearmind Medicine Marketable Securities Historical Data

The historical data trend for Clearmind Medicine's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Marketable Securities Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Marketable Securities

Get a 7-Day Free Trial

0.14

0.06

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Marketable Securities	Get a 7-Day Free Trial															0.14	0.10	0.09	0.06	0.09

Clearmind Medicine Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Clearmind Medicine (NAS:CMND) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Clearmind Medicine Marketable Securities Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.